Long-lasting effects of chronic rTMS to treat chronic rodent model of depression

Behavioural Brain Research

Volumn 232, Issue 1, 2012, Pages 245-251

  Feng, Shu fang ^a   Shi, Tian yao ^b   Fan Yang, ^a   Wang, Wua ning ^a   Chen, Yun chun ^a   Tan, Qing rong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ACTH; BDNF; BrdU; Chronic unpredicted mild stress (CUMS); CORT; Phosphorylated ERK1 2; Repetitive transcranial magnetic stimulation (rTMS)

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BROXURIDINE; CORTICOSTERONE; CORTICOTROPIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SUCROSE; VENLAFAXINE;

ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DEPRESSION; DISEASE MODEL; ENZYME PHOSPHORYLATION; FOOD INTAKE; FORCED SWIMMING TEST; HIPPOCAMPUS; HORMONE BLOOD LEVEL; MALE; NERVE CELL PLASTICITY; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; TASTE PREFERENCE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

ADRENOCORTICOTROPIC HORMONE; ANHEDONIA; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIMETABOLITES; BLOTTING, WESTERN; BODY WEIGHT; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; BROMODEOXYURIDINE; CYCLOHEXANOLS; DEPRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; FOOD PREFERENCES; HYDROCORTISONE; MALE; MAP KINASE SIGNALING SYSTEM; MOTOR ACTIVITY; NEUROGENESIS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL; SWIMMING; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84860641893     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.04.019     Document Type: Article

References (36)

1. Belmaker R.H., Agam G. Major depressive disorder. New England Journal of Medicine 2008, 358:55-68.
2. Fava M. Diagnosis and definition of treatment-resistant depression. Biological Psychiatry 2003, 53:649-659.
3. Rossi S., Hallett M., Rossini P.M., Pascual-Leone A. Safety ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology 2009, 120:2008-2039.
4. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
5. Mineur Y.S., Belzung C., Crusio W.E. Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice. Behavioural Brain Research 2006, 175:43-50.
6. Banasr M., Valentine G.W., Li X.Y., Gourley S.L., Taylor J.R., Duman R.S. Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biological Psychiatry 2007, 62:496-504.
7. Ueyama E., Ukai S., Ogawa A., Yamamoto M., Kawaguchi S., Ishii R., et al. Chronic repetitive transcranial magnetic stimulation increases hippocampal neurogenesis in rats. Psychiatry and Clinical Neurosciences 2011, 65:77-81.
8. Murakami S., Imbe H., Morikawa Y., Kubo C., Senba E. Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neuroscience Research 2005, 53:129-139.
9. West A.E. Biological functions of activity-dependent transcription revealed. Neuron 2008, 60:523-525.
10. Zhang Y., Gu F., Chen J., Dong W. Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat. Brain Research 2010, 1366:141-148.
11. Massa S.M., Yang T., Xie Y., Shi J., Bilgen M., Joyce J.N., et al. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. Journal of Clinical Investigation 2010, 120:1774-1785.
12. Musazzi L., Mallei A., Tardito D., Gruber S.H., El Khoury A., Racagni G., et al. Early-life stress and antidepressant treatment involve synaptic signaling and Erk kinases in a gene-environment model of depression. Journal of Psychiatric Research 2010, 44:511-520.
13. Yung L.Y., Tso P.H., Wu E.H., Yu J.C., Ip N.Y., Wong Y.H. Nerve growth factor-induced stimulation of p38 mitogen-activated protein kinase in PC12 cells is partially mediated via G(i/o) proteins. Cellular Signalling 2008, 20:1538-1544.
14. Qi X., Lin W., Li J., Li H., Wang W., Wang D., et al. Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress. Neurobiology of Disease 2008, 31:278-285.
15. Jiang W., Wan Q., Zhang Z.J., Wang W.D., Huang Y.G., Rao Z.R., et al. Dentate granule cell neurogenesis after seizures induced by pentylenetrazol in rats. Brain Research 2003, 977:141-148.
16. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. Journal of Neuroscience 2000, 20:9104-9110.
17. Hallett M. Transcranial magnetic stimulation and the human brain. Nature 2000, 406:147-150.
18. Keck M.E., Engelmann M., Muller M.B., Henniger M.S., Hermann B., Rupprecht R., et al. Repetitive transcranial magnetic stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. Journal of Psychiatric Research 2000, 34:265-276.
19. Keck M.E., Holsboer F. Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Peptides 2001, 22:835-844.
20. Willner P., Sanger D., Oglesby M. The behavioural pharmacology of anxiety and depression. Behavioural Pharmacology 1997, 8:475-476.
21. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
22. Tonissaar M., Mallo T., Eller M., Haidkind R., Koiv K., Harro J. Rat behavior after chronic variable stress and partial lesioning of 5-HT-ergic neurotransmission: effects of citalopram. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008, 32:164-177.
23. Bessa J.M., Mesquita A.R., Oliveira M., Pego J.M., Cerqueira J.J., Palha J.A., et al. A trans-dimensional approach to the behavioral aspects of depression. Frontiers in Behavioral Neuroscience 2009, 3:1.
24. Holsboer F. The stress hormone system is back on the map. Current Psychiatry Reports 2000, 2:454-456.
25. Pridmore S. Rapid transcranial magnetic stimulation and normalization of the dexamethasone suppression test. Psychiatry and Clinical Neurosciences 1999, 53:33-37.
26. Petrik D., Lagace D.C., Eisch A.J. The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building. Neuropharmacology 2012, 62:21-34.
27. Videbech P., Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. American Journal of Psychiatry 2004, 161:1957-1966.
28. Heine V.M., Maslam S., Zareno J., Joels M., Lucassen P.J. Suppressed proliferation and apoptotic changes in the rat dentate gyrus after acute and chronic stress are reversible. European Journal of Neuroscience 2004, 19:131-144.
29. Lisman J.E., Grace A.A. The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 2005, 46:703-713.
30. Muller M.B., Toschi N., Kresse A.E., Post A., Keck M.E. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology 2000, 23:205-215.
31. Zhang X., Mei Y., Liu C., Yu S. Effect of transcranial magnetic stimulation on the expression of c-Fos and brain-derived neurotrophic factor of the cerebral cortex in rats with cerebral infarct. Journal of Huazhong University of Science and Technology 2007, 27:415-418.
32. Wang H.Y., Crupi D., Liu J., Stucky A., Cruciata G., Di Rocco A., et al. Repetitive transcranial magnetic stimulation enhances BDNF-TrkB signaling in both brain and lymphocyte. Journal of Neuroscience 2011, 31:11044-11054.
33. Duric V., Banasr M., Licznerski P., Schmidt H.D., Stockmeier C.A., Simen A.A., et al. A negative regulator of MAP kinase causes depressive behavior. Nature Medicine 2010, 16:1328-1332.
34. Chen M.J., Nguyen T.V., Pike C.J., Russo-Neustadt A.A. Norepinephrine induces BDNF and activates the PI-3K and MAPK cascades in embryonic hippocampal neurons. Cellular Signalling 2007, 19:114-128.
35. Collazo D., Takahashi H., McKay R.D. Cellular targets and trophic functions of neurotrophin-3 in the developing rat hippocampus. Neuron 1992, 9:643-656.
36. Young D., Lawlor P.A., Leone P., Dragunow M., During M.J. Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nature Medicine 1999, 5:448-453.